1. Home
  2. KROS vs TWI Comparison

KROS vs TWI Comparison

Compare KROS & TWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KROS
  • TWI
  • Stock Information
  • Founded
  • KROS 2015
  • TWI 1890
  • Country
  • KROS United States
  • TWI United States
  • Employees
  • KROS N/A
  • TWI N/A
  • Industry
  • KROS Biotechnology: Pharmaceutical Preparations
  • TWI Steel/Iron Ore
  • Sector
  • KROS Health Care
  • TWI Industrials
  • Exchange
  • KROS Nasdaq
  • TWI Nasdaq
  • Market Cap
  • KROS 565.0M
  • TWI 482.4M
  • IPO Year
  • KROS 2020
  • TWI 1993
  • Fundamental
  • Price
  • KROS $15.22
  • TWI $7.75
  • Analyst Decision
  • KROS Buy
  • TWI Strong Buy
  • Analyst Count
  • KROS 14
  • TWI 2
  • Target Price
  • KROS $20.56
  • TWI $11.50
  • AVG Volume (30 Days)
  • KROS 1.1M
  • TWI 386.0K
  • Earning Date
  • KROS 11-06-2025
  • TWI 11-06-2025
  • Dividend Yield
  • KROS N/A
  • TWI N/A
  • EPS Growth
  • KROS N/A
  • TWI N/A
  • EPS
  • KROS 0.47
  • TWI N/A
  • Revenue
  • KROS $232,844,000.00
  • TWI $1,783,096,000.00
  • Revenue This Year
  • KROS $6,657.47
  • TWI $0.65
  • Revenue Next Year
  • KROS N/A
  • TWI $5.11
  • P/E Ratio
  • KROS $32.70
  • TWI N/A
  • Revenue Growth
  • KROS 85820.30
  • TWI N/A
  • 52 Week Low
  • KROS $9.12
  • TWI $5.93
  • 52 Week High
  • KROS $72.37
  • TWI $10.94
  • Technical
  • Relative Strength Index (RSI)
  • KROS 49.86
  • TWI 49.65
  • Support Level
  • KROS $14.77
  • TWI $7.37
  • Resistance Level
  • KROS $15.30
  • TWI $8.17
  • Average True Range (ATR)
  • KROS 0.65
  • TWI 0.30
  • MACD
  • KROS 0.02
  • TWI 0.05
  • Stochastic Oscillator
  • KROS 75.17
  • TWI 54.84

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

About TWI Titan International Inc. (DE)

Titan International Inc is a manufacturer of wheels, tires, wheel and tire assemblies, and undercarriage systems and components for off-highway vehicles. The company operates through three segments namely Agricultural, Earthmoving/Construction, and Consumer. Geographically, business of the group can be seen in the United States, Europe / CIS, Latin America and Other international. Titan derives majority of the revenue from Agricultural segment which manufacture various agricultural equipment, including tractors, combines, plows, planters and irrigation equipment, and are sold directly to original equipment manufacturers and to the aftermarket through independent distributors, equipment dealers and Titan's own distribution centers.

Share on Social Networks: